Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

TriSalus Life Sciences (TLSI) Invested Capital (2022 - 2025)

Historic Invested Capital for TriSalus Life Sciences (TLSI) over the last 4 years, with Q3 2025 value amounting to $6.0 million.

  • TriSalus Life Sciences' Invested Capital rose 38545.02% to $6.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $6.0 million, marking a year-over-year increase of 38545.02%. This contributed to the annual value of -$3.8 million for FY2024, which is 8592.28% up from last year.
  • TriSalus Life Sciences' Invested Capital amounted to $6.0 million in Q3 2025, which was up 38545.02% from $12.9 million recorded in Q2 2025.
  • TriSalus Life Sciences' Invested Capital's 5-year high stood at $12.9 million during Q2 2025, with a 5-year trough of -$188.3 million in Q2 2023.
  • Its 4-year average for Invested Capital is -$40.6 million, with a median of -$11.5 million in 2022.
  • Its Invested Capital has fluctuated over the past 5 years, first plummeted by 153154.12% in 2023, then skyrocketed by 54886.48% in 2025.
  • Over the past 4 years, TriSalus Life Sciences' Invested Capital (Quarter) stood at -$160.5 million in 2022, then soared by 83.14% to -$27.1 million in 2023, then skyrocketed by 85.92% to -$3.8 million in 2024, then soared by 258.5% to $6.0 million in 2025.
  • Its last three reported values are $6.0 million in Q3 2025, $12.9 million for Q2 2025, and -$2.7 million during Q1 2025.